Data Foundry

Drug recalls 2026

Ranolazine Extended-Release Tablets — Class II drug recall D-0010-2027

Ongoing recall by Ajanta Pharma USA Inc, reported 2026-10-07, distributed nationwide. Failed Dissolution Specifications: below specification

Recall numberD-0010-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAjanta Pharma USA Inc, Bridgewater, NJ, United States
Recall initiated2026-09-17
Classified2026-10-06
Reported by FDA2026-10-07
DistributedNationwide (US)
Reason classesspecification failure
NDC27241-0125, 27241-0125-02, 27241-0125-05, 27241-0126, 27241-0126-02, 27241-0126-05
Lot numbersDJ25134
Expiration dates2028-11-30

Product

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Reason for recall

Failed Dissolution Specifications: below specification

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0010-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-13. Not affiliated with or endorsed by FDA. Not medical or legal advice.